Literature DB >> 22478825

Will Clinical Pathways Work?: Insurers say they are willing to give up control over what they pay for to reduce cancer costs. But oncologists may think differently.

.   

Abstract

Entities:  

Year:  2010        PMID： 22478825      PMCID： PMC2957731     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


× No keyword cloud information.
  1 in total

1.  Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting.

Authors:  Marcus A Neubauer; J Russell Hoverman; Michael Kolodziej; Lonny Reisman; Stephen K Gruschkus; Susan Hoang; Albert A Alva; Marilyn McArthur; Michael Forsyth; Todd Rothermel; Roy A Beveridge
Journal:  J Oncol Pract       Date:  2009-12-30       Impact factor: 3.840
  1 in total
  1 in total

1.  Longitudinal cohort study to determine effectiveness of a novel simulated case and feedback system to improve clinical pathway adherence in breast, lung and GI cancers.

Authors:  Timothy Kubal; Doug G Letson; Alberto A Chiappori; Gregory M Springett; Riti Shimkhada; Diana Tamondong Lachica; John W Peabody
Journal:  BMJ Open       Date:  2016-09-13       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.